文献速递外周血管胸部CTUS

肺动脉动静脉畸形:136例患者长期随访的影像学与临床研究

Pulmonary arteriovenous malformations: a radiological and clinical investigation of 136 patients with long-term follow-up.
PubMed 文献 · Clin Radiol · 2018-08-04

本研究为单中心注册观察性研究,纳入20年间接受栓塞治疗的136例肺动脉动静脉畸形(PAVM)患者(339个PAVM),其中多数合并遗传性出血性毛细血管扩张症(HHT)。随访平均58个月,无分流临床成功率为87%,栓塞相关30天死亡率为0%。多发PAVM与HHT相关,作者建议PAVM患者筛查HHT、HHT患者筛查PAVM。

要点

  • 87%的患者在随访时达到无分流的临床成功,栓塞相关30天死亡率为0%。
  • 多发PAVM与HHT相关;无HHT者更常见单发PAVM。
  • 作者建议PAVM患者筛查HHT,HHT患者筛查PAVM。

核心结论

  • 栓塞是安全的手术,临床成功率高;多数转诊栓塞的PAVM患者有HHT,多发PAVM与HHT相关,PAVM患者应筛查HHT,HHT患者应筛查PAVM。

研究设计与样本

  • 单中心注册观察性研究,纳入20年间所有接受栓塞治疗的PAVM患者136例(339个PAVM),采用临床检查、对比增强超声心动图和CT评估随访结局;HHT患者与非HHT患者进行比较。

诊断标准与关键数值

  • 随访时无分流的临床成功率为87%;栓塞相关30天死亡率为0%;随访期间死亡20例(平均年龄69岁)。

临床应用与阅片要点

  • 作者建议PAVM患者筛查HHT,HHT患者筛查PAVM;多数患者可在一次会话内完成治疗,但许多患者需要长期随访、重复临床检查和栓塞。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To assess the clinical outcome of patients with and without hereditary haemorrhagic telangiectasia (HHT) after embolisation of pulmonary arteriovenous malformations (PAVM) from a single national centre.

MATERIALS AND METHODS: The present register-based observational study including all patients with PAVM treated with embolisation at a reference centre for HHT and PAVM was undertaken over a 20-year period. Demographic data, HHT genotyping, clinical presentation, and outcome were registered. Patients with HHT were compared to the patients without HHT. Clinical examination, contrast-enhanced echocardiography, and computed tomography (CT) were used to assess the clinical outcome at follow-up.

RESULTS: One hundred and thirty-six patients with 339 PAVM underwent embolisation during the study period: 22 did not have HHT; 62% had HHT1, 10% had HHT2, 4% had JP-HHT, 8% had clinical HHT without identified genetic mutations. Solitary PAVM were more common among patients without HHT than with HHT. Mean follow-up after the first embolisation was 58 months. Mean age at first embolisation was 46.5 years, and at last follow-up 51.8 years. The clinical success without shunt at follow-up was 87%. The 30-day mortality related to the embolisation was 0%. Twenty patients died during follow-up (mean age 69 years). Most patients could be treated during one session, but many will need a long follow-up with repeated clinical examinations and embolisation.

CONCLUSION: The majority of patients referred for embolisation of PAVM had HHT. Multiple PAVM is associated with HHT. Patients with PAVM should be screened for HHT and patients with HHT for PAVM. Embolisation is a safe procedure with high clinical success.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Andersen PE, Tørring PM, Duvnjak S, et al. Pulmonary arteriovenous malformations: a radiological and clinical investigation of 136 patients with long-term follow-up. Clin Radiol. 2018. PMID: 30086858. doi:10.1016/j.crad.2018.07.096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。